FindTrial
Sign In

ayurvedic management Of Glaucoma(primary open angle glaucoma)

CLINICAL STUDY ON Primary Open Angle Glaucoma WITH aschyotana,tarpana & oral medication

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/02/006582
Enrollment
30
Registered
2016-02-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- PATIENTS HAVING PRIMARY OPEN ANGLE GLAUCOMA

Interventions

Intervention1: Group A: Tarpana with Shigru pallava arka, Punarnavashtaka Kwath, Gokshuradi Guggulu, Shigru Pallava Arka eye drops, Timolol (0.5 %) Control Intervention1: Group B: Group B (Control Gro

Sponsors

IPGT AND RA GAU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: •Patients of POAG having IOP 21 mmHg. •Visual acuity > 6/60 and clear media.

Exclusion criteria

Exclusion criteria: •All types of PACG will be excluded. •Secondary and developmental Glaucoma including exfoliative Glaucoma, pigmentary Glaucoma, trauma induced, inflammatory Glaucoma. •POAG with advanced stage of optic atrophy. •Visual acuity • All types of cataract will be excluded.

Design outcomes

Secondary

MeasureTime frame
To assess the role of Ayurvedic line of management in lowering IOP.Timepoint: 52—

Primary

MeasureTime frame
1.To propound the concept of chakshushya, rasayana, & diuretic therapy in the management of POAG. 2.To evaluate the Neuroprotective effect of Ayurvedic line of management in POAG. Timepoint: 52 days—

Countries

India

Contacts

Public ContactDr Majusha Rajgopala

IPGT AND RA, G.A.U. JAMNAGAR

bhatrajma2008@gmail.com9428400759

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026